Literature DB >> 1381301

Cells with natural killer activity in human rabies.

T Panpanich1, T Hemachudha, S Piyasirisilp, S Manatsathit, H Wilde, P Phanuphak.   

Abstract

Cytotoxic lymphocyte function in 13 patients with rabies was studied by counting the number of CD56 cells and assessing natural killer (NK) cell activity. There was no significant difference in the number of killer cells between rabies patients and 31 normal controls (P greater than 0.05). Two of six non-fatal encephalitic patients due to causes other than rabies had reduced CD56 numbers. Base-line NK cell responses versus K562 cell targets did not differ among the normal control and rabies groups (P greater than 0.05). Study of the non-rabies encephalitis group showed heterogeneous results with wide variation. Significant enhancement of NK activity was seen in four rabies patients and in 10 normal control subjects tested after interferon-alpha (IFN-alpha) and IL-2. None of the four patients with encephalitis due to causes other than rabies showed such enhancement. Our results suggest that NK cells of rabies patients are not fully stimulated and that this might contribute to the virulence of rabies. The cause of this phenomenon remains unknown.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1381301      PMCID: PMC1554463          DOI: 10.1111/j.1365-2249.1992.tb06972.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  21 in total

1.  Lymphocyte subsets in human encephalitic and paralytic rabies.

Authors:  B Sriwanthana; T Hemachudha; D E Griffin; S Manutsathit; D Tweardy; P Phanuphak
Journal:  Acta Neurol Scand       Date:  1989-10       Impact factor: 3.209

2.  Genetic control of serum neutralizing-antibody response to rabies vaccination and survival after a rabies challenge infection in mice.

Authors:  J W Templeton; C Holmberg; T Garber; R M Sharp
Journal:  J Virol       Date:  1986-07       Impact factor: 5.103

3.  Natural cytotoxic reactivity of human lymphocytes against a myeloid cell line: characterization of effector cells.

Authors:  W H West; G B Cannon; H D Kay; G D Bonnard; R B Herberman
Journal:  J Immunol       Date:  1977-01       Impact factor: 5.422

4.  Rabies vaccines: duration-of-immunity study in dogs.

Authors:  R K Sikes; G V Peacock; P Acha; R J Arko; R Dierks
Journal:  J Am Vet Med Assoc       Date:  1971-12-01       Impact factor: 1.936

5.  Generation of monoclonal antibodies to a human natural killer clone. Characterization of two natural killer-associated antigens, NKH1A and NKH2, expressed on subsets of large granular lymphocytes.

Authors:  T Hercend; J D Griffin; A Bensussan; R E Schmidt; M A Edson; A Brennan; C Murray; J F Daley; S F Schlossman; J Ritz
Journal:  J Clin Invest       Date:  1985-03       Impact factor: 14.808

6.  Natural killer cell activity during measles.

Authors:  D E Griffin; B J Ward; E Jauregui; R T Johnson; A Vaisberg
Journal:  Clin Exp Immunol       Date:  1990-08       Impact factor: 4.330

7.  Human immune response to rabies nucleocapsid and glycoprotein antigens.

Authors:  S Kasempimolporn; T Hemachudha; P Khawplod; S Manatsathit
Journal:  Clin Exp Immunol       Date:  1991-05       Impact factor: 4.330

8.  Cells with natural killer activity in the cerebrospinal fluid of normal mice and athymic nude mice with acute Sindbis virus encephalitis.

Authors:  D E Griffin; J L Hess
Journal:  J Immunol       Date:  1986-03-01       Impact factor: 5.422

9.  Pathogenesis of street rabies virus infections in resistant and susceptible strains of mice.

Authors:  D L Lodmell; L C Ewalt
Journal:  J Virol       Date:  1985-09       Impact factor: 5.103

10.  Natural killer cell depletion enhances virus synthesis and virus-induced hepatitis in vivo.

Authors:  J F Bukowski; B A Woda; S Habu; K Okumura; R M Welsh
Journal:  J Immunol       Date:  1983-09       Impact factor: 5.422

View more
  1 in total

Review 1.  Subversion of the Immune Response by Rabies Virus.

Authors:  Terence P Scott; Louis H Nel
Journal:  Viruses       Date:  2016-08-19       Impact factor: 5.048

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.